Daiwa Securities Group Inc. Increases Stake in Teleflex Incorporated (TFX)
Daiwa Securities Group Inc. increased its position in Teleflex Incorporated (NYSE:TFX) by 66.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,750 shares of the medical technology company’s stock after buying an additional 1,100 shares during the period. Daiwa Securities Group Inc.’s holdings in Teleflex were worth $571,000 at the end of the most recent reporting period.
Other institutional investors also recently added to or reduced their stakes in the company. UBS Asset Management Americas Inc. increased its position in shares of Teleflex by 118.9% in the fourth quarter. UBS Asset Management Americas Inc. now owns 72,560 shares of the medical technology company’s stock worth $11,692,000 after buying an additional 39,419 shares in the last quarter. Teachers Advisors LLC increased its position in shares of Teleflex by 4.8% in the fourth quarter. Teachers Advisors LLC now owns 45,560 shares of the medical technology company’s stock worth $7,342,000 after buying an additional 2,074 shares in the last quarter. Creative Planning increased its position in shares of Teleflex by 3.7% in the first quarter. Creative Planning now owns 2,259 shares of the medical technology company’s stock worth $438,000 after buying an additional 81 shares in the last quarter. Fox Run Management L.L.C. acquired a new position in shares of Teleflex during the first quarter worth $349,000. Finally, Louisiana State Employees Retirement System increased its position in shares of Teleflex by 3.7% in the first quarter. Louisiana State Employees Retirement System now owns 11,300 shares of the medical technology company’s stock worth $2,189,000 after buying an additional 400 shares in the last quarter. 93.02% of the stock is owned by institutional investors.
Teleflex Incorporated (TFX) opened at 205.34 on Friday. Teleflex Incorporated has a 52 week low of $136.53 and a 52 week high of $217.97. The company has a market cap of $9.25 billion, a P/E ratio of 39.27 and a beta of 1.05. The firm’s 50 day moving average is $209.41 and its 200-day moving average is $196.91.
Teleflex (NYSE:TFX) last announced its quarterly earnings results on Thursday, August 3rd. The medical technology company reported $2.04 earnings per share for the quarter, topping the consensus estimate of $1.91 by $0.13. Teleflex had a net margin of 12.36% and a return on equity of 16.12%. The firm had revenue of $528.60 million during the quarter, compared to analysts’ expectations of $518.98 million. During the same quarter in the prior year, the company earned $1.89 EPS. The company’s revenue was up 11.6% compared to the same quarter last year. On average, analysts predict that Teleflex Incorporated will post $8.28 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 15th. Investors of record on Tuesday, August 15th will be paid a dividend of $0.34 per share. The ex-dividend date is Friday, August 11th. This represents a $1.36 annualized dividend and a dividend yield of 0.66%. Teleflex’s dividend payout ratio (DPR) is presently 26.00%.
TRADEMARK VIOLATION WARNING: “Daiwa Securities Group Inc. Increases Stake in Teleflex Incorporated (TFX)” was first posted by Daily Political and is the property of of Daily Political. If you are reading this article on another website, it was stolen and reposted in violation of U.S. and international copyright & trademark legislation. The legal version of this article can be accessed at https://www.dailypolitical.com/2017/08/13/daiwa-securities-group-inc-increases-stake-in-teleflex-incorporated-tfx.html.
TFX has been the subject of a number of analyst reports. Zacks Investment Research raised shares of Teleflex from a “hold” rating to a “buy” rating and set a $228.00 target price for the company in a research note on Friday, June 23rd. Barclays PLC reaffirmed a “buy” rating on shares of Teleflex in a research note on Monday, June 26th. Deutsche Bank AG raised their target price on shares of Teleflex from $213.00 to $220.00 and gave the company a “buy” rating in a research note on Monday, May 8th. Needham & Company LLC reaffirmed a “buy” rating and set a $224.00 target price on shares of Teleflex in a research note on Friday, May 5th. Finally, Leerink Swann raised their target price on shares of Teleflex from $215.00 to $220.00 and gave the company a “market perform” rating in a research note on Friday, June 9th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and six have issued a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $228.00.
In related news, Director Stephen K. M.D. Klasko sold 200 shares of the business’s stock in a transaction that occurred on Thursday, June 1st. The shares were sold at an average price of $199.93, for a total transaction of $39,986.00. Following the completion of the transaction, the director now owns 8,080 shares in the company, valued at approximately $1,615,434.40. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Stephen K. M.D. Klasko sold 5,200 shares of the business’s stock in a transaction that occurred on Monday, May 15th. The stock was sold at an average price of $193.56, for a total transaction of $1,006,512.00. Following the transaction, the director now owns 12,880 shares of the company’s stock, valued at approximately $2,493,052.80. The disclosure for this sale can be found here. In the last quarter, insiders have sold 8,300 shares of company stock valued at $1,643,975. 2.39% of the stock is currently owned by company insiders.
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX).
Receive News & Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.